=

Biogen CEO ‘reasonably confident’ once-doomed Alzheimer’s drug will be granted FDA approval

111111111

October 23, 2019 0 Comments
“This was a thorough engagement, and as CEO I’m reasonably confident this will lead to market approval one day,” Biogen CEO Michel Vounatsos says.
Tags:
Share: